Quoin Pharmaceuticals, Ltd. (QNRX)
NASDAQ: QNRX · Real-Time Price · USD
6.12
+0.96 (18.72%)
At close: Aug 28, 2026, 4:00 PM EDT
5.70
-0.42 (-6.86%)
After-hours: Aug 28, 2026, 7:59 PM EDT
Quoin Pharmaceuticals Stock Forecast
Stock Price Forecast
According to 5 analysts polled by S&P Global, Quoin Pharmaceuticals stock has a consensus rating of "Strong Buy" and an average price target of $21.4. The average 1-year stock price forecast is 249.67% higher than the current stock price, while the lowest is $12 (+96.08%) and the highest is $35 (+471.90%).
Price Target: $21.4 (+249.67%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Quoin Pharmaceuticals stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Mar '26 | Apr '26 | May '26 | Jun '26 | Jul '26 | Aug '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 2 | 3 | 3 | 3 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 3 | 4 | 4 | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Alliance Global Partners | Alliance Global Partners | Buy Reiterates $35 | Buy | Reiterates | $35 | +471.90% | Aug 18, 2026 |
| Maxim Group | Maxim Group | Buy Reiterates $16 | Buy | Reiterates | $16 | +161.44% | Jul 10, 2026 |
| ThinkEquity | ThinkEquity | Buy Initiates $12 | Buy | Initiates | $12 | +96.08% | Jun 15, 2026 |
| Lucid Capital | Lucid Capital | Buy Initiates $30 | Buy | Initiates | $30 | +390.20% | May 4, 2026 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-7.17
EPS Next Year
-3.19
from -7.17
EPS and Forward PE are based on non-GAAP adjusted numbers.